Toxikon Forms Partnership with Ocean Ridge Biosciences


Toxikon, a preclinical contract research organization that provides development services to the biotechnology, pharmaceutical, and medical device industries, and Ocean Ridge Biosciences (ORB), a genomic services provider to the health care and life science industries, have formed a partnership to globally market their respective expertise and provide increased discovery through preclinical development services to its clients.
read more

Submitted by oceanrid on Wed Oct 26, 2011 12:12 PM


ORB awarded grant for development of prognostic biomarkers of Emphysema


Ocean Ridge Biosciences, LLC (ORB) today announced that it has been awarded a $69,435 grant under the Therapeutic Discovery Tax Credit program that was enacted under the U.
read more

Submitted by oceanrid on Wed Oct 26, 2011 12:12 PM